Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8898350rdf:typepubmed:Citationlld:pubmed
pubmed-article:8898350lifeskim:mentionsumls-concept:C0206131lld:lifeskim
pubmed-article:8898350lifeskim:mentionsumls-concept:C0010661lld:lifeskim
pubmed-article:8898350lifeskim:mentionsumls-concept:C0013081lld:lifeskim
pubmed-article:8898350lifeskim:mentionsumls-concept:C0127400lld:lifeskim
pubmed-article:8898350pubmed:issue1lld:pubmed
pubmed-article:8898350pubmed:dateCreated1997-2-18lld:pubmed
pubmed-article:8898350pubmed:abstractTextInsulin receptor substrate-1 (IRS-1) is a protein expressed in 3T3-L1 adipocytes that is involved in most, if not all of the biological responses to insulin. Chronic exposure of these cells to insulin down-regulates IRS-1 by stimulating its degradation (Rice, K.M., Turnbow, M.A. and Garner, C.W. (1993) Biochem. Biophys. Res. Commun. 190, 961-967). This insulin-induced down-regulation of IRS-1 was totally abolished by BAPTA-AM (cell-permeable calcium chelator), E-64d (cell-permeable thiol protease inhibitor), Cbz-Leu-Nleu-H and Cbz-Leu-Leu-Tyr-CHN2 (selective cell-permeable calpain inhibitor peptides). Calpastatin (specific calpain inhibitor protein) also inhibited the insulin-induced down-regulation of IRS-1 in transiently permeabilized cells. In addition, 3T3-L1 adipocytes express endogenous calpain which can degrade IRS-1 in cell-free extracts. These results suggest that the insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes is mediated by a calcium-dependent thiol protease which is sensitive to inhibition by calpain inhibitors.lld:pubmed
pubmed-article:8898350pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8898350pubmed:languageenglld:pubmed
pubmed-article:8898350pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8898350pubmed:citationSubsetIMlld:pubmed
pubmed-article:8898350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8898350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8898350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8898350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8898350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8898350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8898350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8898350pubmed:statusMEDLINElld:pubmed
pubmed-article:8898350pubmed:monthAuglld:pubmed
pubmed-article:8898350pubmed:issn0303-7207lld:pubmed
pubmed-article:8898350pubmed:authorpubmed-author:GarnerC WCWlld:pubmed
pubmed-article:8898350pubmed:authorpubmed-author:SmithL KLKlld:pubmed
pubmed-article:8898350pubmed:authorpubmed-author:RiceK MKMlld:pubmed
pubmed-article:8898350pubmed:issnTypePrintlld:pubmed
pubmed-article:8898350pubmed:day30lld:pubmed
pubmed-article:8898350pubmed:volume122lld:pubmed
pubmed-article:8898350pubmed:ownerNLMlld:pubmed
pubmed-article:8898350pubmed:authorsCompleteYlld:pubmed
pubmed-article:8898350pubmed:pagination81-92lld:pubmed
pubmed-article:8898350pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:8898350pubmed:meshHeadingpubmed-meshheading:8898350-...lld:pubmed
pubmed-article:8898350pubmed:meshHeadingpubmed-meshheading:8898350-...lld:pubmed
pubmed-article:8898350pubmed:meshHeadingpubmed-meshheading:8898350-...lld:pubmed
pubmed-article:8898350pubmed:meshHeadingpubmed-meshheading:8898350-...lld:pubmed
pubmed-article:8898350pubmed:meshHeadingpubmed-meshheading:8898350-...lld:pubmed
pubmed-article:8898350pubmed:meshHeadingpubmed-meshheading:8898350-...lld:pubmed
pubmed-article:8898350pubmed:meshHeadingpubmed-meshheading:8898350-...lld:pubmed
pubmed-article:8898350pubmed:meshHeadingpubmed-meshheading:8898350-...lld:pubmed
pubmed-article:8898350pubmed:meshHeadingpubmed-meshheading:8898350-...lld:pubmed
pubmed-article:8898350pubmed:meshHeadingpubmed-meshheading:8898350-...lld:pubmed
pubmed-article:8898350pubmed:meshHeadingpubmed-meshheading:8898350-...lld:pubmed
pubmed-article:8898350pubmed:meshHeadingpubmed-meshheading:8898350-...lld:pubmed
pubmed-article:8898350pubmed:year1996lld:pubmed
pubmed-article:8898350pubmed:articleTitleThe insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes is mediated by a calcium-dependent thiol protease.lld:pubmed
pubmed-article:8898350pubmed:affiliationDepartment of Cell Biology and Biochemistry, Texas Tech University, Health Sciences Center, Lubbock 79430, USA.lld:pubmed
pubmed-article:8898350pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8898350pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8898350pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8898350lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8898350lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8898350lld:pubmed